Anand A, Ayanian H, Digenis-Bury E, Dodds HD, Dooley D, Fuster M, Mutonyi M, Panati S, Plummer KM, Saltus C, Shah SN, Sims PD. Health of Boston 2009. Boston: MA. Boston Public Health Commission; 2010.
Perez-Gutthann S, de Abajo F, Garcia Rodriguez LA, Varas-Lorenzo C, Gutierrez L, Castellsague J. Pharmacoepidemiology: Epidemiology applied to pharmaceutical development, safety and risk. In: Hernández G, Moreno A, Zaragoza F, Porras A, editors. MEDIPHARM: Tratado de Medicina Farmacéutica. Madrid: Spain. Médica Panamericana; 2010.
Anthony MS, Anderson JJB, Alekel DL. Association between soy and/or isoflavones and bone: evidence from epidemiologic studies. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.331-40.
Vitolins MZ, Anthony MS, Burke GL. Use of soy isoflavones as an alternative to traditional hormone replacement therapy. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.520-36.
Vitolins MZ, Anthony MS, Burke GL. Epidemiology of soy isoflavones and cardiovascular disease. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.260-7.
Mansfield CA, Smith VK. Tradeoff at the trough: tMDLs and the evolving status of water quality policy. In: List J, de Zeeuw A, editors. Recent advances in environmental economics. Cheltenhen: United Kingdom. Edward Elgar; 2002.
Anthony MS. Soy/isoflavones and risk factors for cardiovascular disease. In: Gilani GS, Anderson JJB, editors. Phytoestrogens and health. Champaign: IL. AOCS Press; 2002. p.268-89.